193 related articles for article (PubMed ID: 34793867)
1. Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning.
Saboo K; Petrakov NV; Shamsaddini A; Fagan A; Gavis EA; Sikaroodi M; McGeorge S; Gillevet PM; Iyer RK; Bajaj JS
J Hepatol; 2022 Mar; 76(3):600-607. PubMed ID: 34793867
[TBL] [Abstract][Full Text] [Related]
2. Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy.
Saboo K; Shamsaddini A; Iyer MV; Hu C; Fagan A; Gavis EA; White MB; Fuchs M; Heuman DM; Sikaroodi M; Iyer RK; Gillevet PM; Bajaj JS
J Hepatol; 2021 Jan; 74(1):80-88. PubMed ID: 32679299
[TBL] [Abstract][Full Text] [Related]
3. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.
Bajaj JS; Betrapally NS; Hylemon PB; Heuman DM; Daita K; White MB; Unser A; Thacker LR; Sanyal AJ; Kang DJ; Sikaroodi M; Gillevet PM
Hepatology; 2015 Oct; 62(4):1260-71. PubMed ID: 25820757
[TBL] [Abstract][Full Text] [Related]
4. Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy.
Bajaj JS; Fagan A; White MB; Wade JB; Hylemon PB; Heuman DM; Fuchs M; John BV; Acharya C; Sikaroodi M; Gillevet PM
Am J Gastroenterol; 2019 Jul; 114(7):1080-1090. PubMed ID: 30816877
[TBL] [Abstract][Full Text] [Related]
5. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.
Bajaj JS; Hylemon PB; Ridlon JM; Heuman DM; Daita K; White MB; Monteith P; Noble NA; Sikaroodi M; Gillevet PM
Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(6):G675-85. PubMed ID: 22821944
[TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.
Bajaj JS; Acharya C; Fagan A; White MB; Gavis E; Heuman DM; Hylemon PB; Fuchs M; Puri P; Schubert ML; Sanyal AJ; Sterling RK; Stravitz TR; Siddiqui MS; Luketic V; Lee H; Sikaroodi M; Gillevet PM
Am J Gastroenterol; 2018 Aug; 113(8):1177-1186. PubMed ID: 29872220
[TBL] [Abstract][Full Text] [Related]
7. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.
Bajaj JS; Cox IJ; Betrapally NS; Heuman DM; Schubert ML; Ratneswaran M; Hylemon PB; White MB; Daita K; Noble NA; Sikaroodi M; Williams R; Crossey MM; Taylor-Robinson SD; Gillevet PM
Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G951-7. PubMed ID: 25258407
[TBL] [Abstract][Full Text] [Related]
8. Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial.
Patel VC; Lee S; McPhail MJW; Da Silva K; Guilly S; Zamalloa A; Witherden E; Støy S; Manakkat Vijay GK; Pons N; Galleron N; Huang X; Gencer S; Coen M; Tranah TH; Wendon JA; Bruce KD; Le Chatelier E; Ehrlich SD; Edwards LA; Shoaie S; Shawcross DL
J Hepatol; 2022 Feb; 76(2):332-342. PubMed ID: 34571050
[TBL] [Abstract][Full Text] [Related]
9. Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy.
Bajaj JS; Sikaroodi M; Shamsaddini A; Henseler Z; Santiago-Rodriguez T; Acharya C; Fagan A; Hylemon PB; Fuchs M; Gavis E; Ward T; Knights D; Gillevet PM
Gut; 2021 Jun; 70(6):1162-1173. PubMed ID: 32998876
[TBL] [Abstract][Full Text] [Related]
10. Altered profile of human gut microbiome is associated with cirrhosis and its complications.
Bajaj JS; Heuman DM; Hylemon PB; Sanyal AJ; White MB; Monteith P; Noble NA; Unser AB; Daita K; Fisher AR; Sikaroodi M; Gillevet PM
J Hepatol; 2014 May; 60(5):940-7. PubMed ID: 24374295
[TBL] [Abstract][Full Text] [Related]
11. The role of microbiota in hepatic encephalopathy.
Bajaj JS
Gut Microbes; 2014; 5(3):397-403. PubMed ID: 24690956
[TBL] [Abstract][Full Text] [Related]
12. Stool microbiota show greater linkages with plasma metabolites compared to salivary microbiota in a multinational cirrhosis cohort.
Cox IJ; Peña Rodríguez M; Fagan A; Rojas-Lara MV; Le Guennec A; Rodriguez-Alvarez F; McGeorge S; Escalona-Nandez I; Torre A; Bajaj JS
Liver Int; 2022 Oct; 42(10):2274-2282. PubMed ID: 35635305
[TBL] [Abstract][Full Text] [Related]
13. Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy.
Bloom PP; Luévano JM; Miller KJ; Chung RT
Ann Hepatol; 2021; 25():100333. PubMed ID: 33621653
[TBL] [Abstract][Full Text] [Related]
14. Influence of proton pump inhibitors on microbiota in chronic liver disease patients.
Yamamoto K; Ishigami M; Honda T; Takeyama T; Ito T; Ishizu Y; Kuzuya T; Hayashi K; Goto H; Hirooka Y
Hepatol Int; 2019 Mar; 13(2):234-244. PubMed ID: 30737678
[TBL] [Abstract][Full Text] [Related]
15. Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis.
Shamsaddini A; Gillevet PM; Acharya C; Fagan A; Gavis E; Sikaroodi M; McGeorge S; Khoruts A; Albhaisi S; Fuchs M; Sterling RK; Bajaj JS
Gastroenterology; 2021 Aug; 161(2):508-521.e7. PubMed ID: 33857456
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus.
Bajaj JS; Betrapally NS; Hylemon PB; Thacker LR; Daita K; Kang DJ; White MB; Unser AB; Fagan A; Gavis EA; Sikaroodi M; Dalmet S; Heuman DM; Gillevet PM
Sci Rep; 2015 Dec; 5():18559. PubMed ID: 26692421
[TBL] [Abstract][Full Text] [Related]
17. Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosis.
Bajaj JS; Thacker LR; Fagan A; White MB; Gavis EA; Hylemon PB; Brown R; Acharya C; Heuman DM; Fuchs M; Dalmet S; Sikaroodi M; Gillevet PM
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515036
[TBL] [Abstract][Full Text] [Related]
18. Linkage of gut microbiome with cognition in hepatic encephalopathy.
Bajaj JS; Ridlon JM; Hylemon PB; Thacker LR; Heuman DM; Smith S; Sikaroodi M; Gillevet PM
Am J Physiol Gastrointest Liver Physiol; 2012 Jan; 302(1):G168-75. PubMed ID: 21940902
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy.
Schulz C; Schütte K; Vilchez-Vargas R; Vasapolli R; Malfertheiner P
Dig Dis; 2019; 37(2):161-169. PubMed ID: 30428474
[TBL] [Abstract][Full Text] [Related]
20. Posttraumatic stress disorder is associated with altered gut microbiota that modulates cognitive performance in veterans with cirrhosis.
Bajaj JS; Sikaroodi M; Fagan A; Heuman D; Gilles H; Gavis EA; Fuchs M; Gonzalez-Maeso J; Nizam S; Gillevet PM; Wade JB
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G661-G669. PubMed ID: 31460790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
